Hemodynamic effects of lisinopril after long-term administration in congestive heart failure
- 1 March 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (9) , 567-570
- https://doi.org/10.1016/0002-9149(89)90900-4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Modulation of hemodynamic effects with a converting enzyme inhibitor: Acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesAmerican Heart Journal, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failureAmerican Heart Journal, 1986
- Enalapril in congestive heart failure: acute and chronic invasive hemodynamic evaluationInternational Journal of Cardiology, 1986
- Controlled trial of enalapril in congestive cardiac failure.Heart, 1985
- Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failureJournal of the American College of Cardiology, 1985
- Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.Heart, 1983
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979